GeoVax Labs has experienced a rise in its stock price due to several positive developments. The CEO, David…
This article Strong buy ratings, government support, and promising trials? đź“Š GeoVax Labs is stacking the odds in their favor appeared first on Guerilla Stock Trading.
Shell nears resolution in valuation dispute, paving way for $1 bln asset sale, Bloomberg reports Source link
Why Vertex Pharmaceuticals Continues To Outperfrom Source link
December 16, 2025December 16, 2025 Shares of Atlantaa Ltd were locked 5% higher on 16 December after the company registered the Development Agreement for the redevelopment of the “Bansi Nagar” project in Mumbai. In its regulatory filing, the company said, “We wish to inform that Atlantaa Limited has registered…
4 reasons why the ASX 200 will struggle in September​ By Kerry Sun Wed 03 Sep 25, 2:42pm (AEST) Key Points September historically delivers the worst ASX performance with average -0.11% returns and only 52.5% success rate, with weakness intensifying over recent years to -2.2% average over the past five years.Bell Potter’s Richard Coppleson sees…
Boston Trust Walden Corp trimmed its holdings in shares of Lamar Advertising Company (NASDAQ:LAMR – Free Report) by 13.9% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 371,788 shares of the real estate investment trust’s stock af Source link
Canadian pensioners are using their self-directed Tax-Free Savings Account (TFSA) to build portfolios of dividend stocks that can generate reliable and growing passive income. Enbridge Enbridge (TSX:ENB) trades near $61 at the time of writing, compared to the 2025 high of around $65, so investors have a chance to buy the stock on a dip….